We found that both compounds were able to increase control, SOD1 and TDP-43 fALS MN viability and neurite morphology, and that this rescue was greater than that of riluzole or edaravone, 2 FDA approved drugs for ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.